WO2007026035A3 - Use of a mycosporin-type amino acid (porphyra 334) as an antioxidant - Google Patents
Use of a mycosporin-type amino acid (porphyra 334) as an antioxidant Download PDFInfo
- Publication number
- WO2007026035A3 WO2007026035A3 PCT/ES2006/000488 ES2006000488W WO2007026035A3 WO 2007026035 A3 WO2007026035 A3 WO 2007026035A3 ES 2006000488 W ES2006000488 W ES 2006000488W WO 2007026035 A3 WO2007026035 A3 WO 2007026035A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- porphyra
- mycosporin
- amino acid
- antioxidant
- type amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/04—Rhodophycota or rhodophyta (red algae), e.g. Porphyra
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Birds (AREA)
- Ophthalmology & Optometry (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a mycosporin-type amino acid (porphyra 334) which can be used as an antioxidant and which is suitable for use in the biotechnological industry. The invention outlines the potential use of a mycosporin (MAA)-type amino acid as an antioxidant substance, specifically porphyra 334 isolated from red alga Porphyra leucostica, and to the possible use thereof in pharmaceutical, nutraceutical or functional food preparations, among others, for the prevention of oxidative stress.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200502161A ES2301293B1 (en) | 2005-08-31 | 2005-08-31 | USE OF MICOSPORINE TYPE AMINO ACID (PORPHYRA 334) AS AN ANTIOXIDANT. |
| ESP200502161 | 2005-08-31 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2007026035A2 WO2007026035A2 (en) | 2007-03-08 |
| WO2007026035A3 true WO2007026035A3 (en) | 2007-05-10 |
Family
ID=37809229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/ES2006/000488 Ceased WO2007026035A2 (en) | 2005-08-31 | 2006-08-28 | Use of a mycosporin-type amino acid (porphyra 334) as an antioxidant |
Country Status (2)
| Country | Link |
|---|---|
| ES (6) | ES2301293B1 (en) |
| WO (1) | WO2007026035A2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2317741B1 (en) * | 2006-06-20 | 2010-02-10 | Universidad De Malaga | COMPOSITION FOR SOLAR PROTECTION BASED ON ALGAE AND LIQUEN EXTRACTS. |
| KR102196422B1 (en) * | 2019-07-15 | 2020-12-30 | 주식회사 바이오에프디엔씨 | Method of cell reprogramming adult cell to induced pluripotent stem cell using Porphyra334 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000024369A1 (en) * | 1998-10-23 | 2000-05-04 | Nouvab Inc | Solar radiation protection composition |
| WO2002039974A1 (en) * | 2000-11-17 | 2002-05-23 | Natural Environment Research Council | Personal care compositions |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2655268B1 (en) * | 1989-12-06 | 1994-10-14 | Secma | USE OF ALGAE EXTRACTS FOR THE PREPARATION OF PHARMACEUTICAL, COSMETIC, FOOD OR AGRICULTURAL COMPOSITIONS. |
| FR2803201B1 (en) * | 1999-12-30 | 2004-11-26 | Gelyma | ALGAE EXTRACT WITH FILTERING ACTIVITY WITH RESPECT TO ULTRAVIOLET RADIATION |
| ATE420623T1 (en) * | 2001-11-14 | 2009-01-15 | Larena | MEDIUM CONTAINING A RED ALGAE EXTRACT OF THE GENUS PORPHYRA AND ITS USE TO PROTECT CELLS |
| FR2882894B1 (en) * | 2005-03-11 | 2009-04-03 | Larena Sa | SUPPLETIVE FOOD COMPOSITION |
-
2005
- 2005-08-31 ES ES200502161A patent/ES2301293B1/en not_active Expired - Fee Related
- 2005-08-31 ES ES200702945A patent/ES2301435B1/en not_active Expired - Fee Related
- 2005-08-31 ES ES200702947A patent/ES2301437B1/en not_active Expired - Fee Related
- 2005-08-31 ES ES200702946A patent/ES2301436B1/en not_active Expired - Fee Related
- 2005-08-31 ES ES200702943A patent/ES2301433A1/en active Pending
- 2005-08-31 ES ES200702944A patent/ES2301434B1/en not_active Expired - Fee Related
-
2006
- 2006-08-28 WO PCT/ES2006/000488 patent/WO2007026035A2/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000024369A1 (en) * | 1998-10-23 | 2000-05-04 | Nouvab Inc | Solar radiation protection composition |
| WO2002039974A1 (en) * | 2000-11-17 | 2002-05-23 | Natural Environment Research Council | Personal care compositions |
Also Published As
| Publication number | Publication date |
|---|---|
| ES2301436A1 (en) | 2008-06-16 |
| ES2301437B1 (en) | 2009-05-01 |
| ES2301434B1 (en) | 2009-05-01 |
| ES2301434A1 (en) | 2008-06-16 |
| ES2301436B1 (en) | 2009-05-08 |
| ES2301435A1 (en) | 2008-06-16 |
| ES2301433A1 (en) | 2008-06-16 |
| ES2301293B1 (en) | 2009-05-01 |
| WO2007026035A2 (en) | 2007-03-08 |
| ES2301435B1 (en) | 2009-05-01 |
| ES2301293A1 (en) | 2008-06-16 |
| ES2301437A1 (en) | 2008-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2003041679A3 (en) | Product containing a red alga extract of the genus porphyra and uses thereof for protecting cells | |
| WO2011100763A3 (en) | Ruminant dietary supplement compositions and methods of manufacturing and using the same | |
| WO2009017840A9 (en) | Protein and isolated or purified amino acid product containing compositions and uses thereof | |
| IL196133A0 (en) | Extracts of aphanizomenon flos aquae and nutritional, cosmetic and pharmaceutical compositions containing the same | |
| WO2008036932A3 (en) | Compositions and methods comprising boswellia species | |
| WO2007079139A3 (en) | Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide | |
| Nwachukwu et al. | Antioxidant properties of flaxseed protein hydrolysates: influence of hydrolytic enzyme concentration and peptide size | |
| WO2007059715A3 (en) | Methods and proteins for the prophylactic and/or therapeutic treatment of the four serotypes of dengue virus and other flaviviruses | |
| WO2004087203A3 (en) | Immunostimulatory nucleic acid oil-in-water formulations for topical application | |
| WO2010130832A3 (en) | Amino acid sequences directed against dickkopf-1 and polypeptides comprising the same for the treatment of diseases and disorders associated with bone loss and/or osteolytic lesions | |
| ATE402143T1 (en) | METHOD FOR OBTAINING NEW LUTEIN-BASED FORMULATIONS | |
| WO2005082927A3 (en) | Antihypertensive peptides | |
| CO5700787A2 (en) | COMPOSITIONS WITH A CONTENT OF ENZYMES, DIETETIC FOODS AND MEDICINES PRODUCED FROM THEM, AND ITS USE FOR MEDICINAL PURPOSES | |
| WO2011152330A1 (en) | Soybean protein hydrolysate-containing antioxidant and use thereof | |
| ATE388166T1 (en) | BIOACTIVE PEPTIDES OBTAINED FROM THE PROTEINS OF PROTEIN BY ENZYMATIC HYDROLYSIS | |
| Boah et al. | In-vitro antioxident and free radical scavenging activity of Alternanthera sessilis | |
| WO2006034172A3 (en) | GLYCININ-RICH AND β-CONGLYCININ-RICH VEGETABLE PROTEIN FRACTIONS | |
| WO2009125409A3 (en) | Fatty acid amides and uses thereof | |
| WO2003050067A3 (en) | Vitamin d analogues | |
| NZ585092A (en) | Food material for inhibiting osteoclastogenesis | |
| WO2007026035A3 (en) | Use of a mycosporin-type amino acid (porphyra 334) as an antioxidant | |
| WO2005074989A3 (en) | Combination of a dna topoisomerase inhibitor and an iap inhibitor | |
| WO2010090498A3 (en) | Pharmaceutical composition and health food composition containing youngia denticulata extract, fraction thereof, or compound isolated therefrom as active ingredient for improving liver function | |
| WO2007026038A3 (en) | Use of a mycosporin-type amino acid (shinorine) as an antioxidant | |
| WO2007026037A3 (en) | Use of a mixture of mycosporin-type amino acids (asterin 330 + palythine) as an antioxidant |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 06807933 Country of ref document: EP Kind code of ref document: A2 |